Since the launch of its first retinal camera in 1962, Kowa has been devoted to producing the most innovative optical products and integrated technology solutions in the world.
Kowa ophthalmic diagnostics products set clinical standards for diagnosis of a wide range of ophthalmic conditions and have been designed and engineered to provide easy-to-use solutions for healthcare professionals, so that they can continue to offer the very best in patient care.
A leader in the Japanese Intra Ocular Lens (IOL) market the second largest market in the world AvanseeTM set new standards for quality and ease of use for monofocal and Toric preloaded intraocular lenses.
Kowa have also produced several ophthalmic solutions for a number of debilitating eye disorders (currently marketed in Japan only):
- Neosynesin Kowa 5% eye solution (phenylephrine hydrochloride) for mydriasis ─ for the purpose of diagnosis or treatment
- Hypadil Kowa 0.25% ophthalmic solution (nipradilol) for glaucoma and intraocular hypertension
- Zepelin ophthalmic solution (acitazanolast hydrate) for allergic conjunctivitis
- GLANATEC® ophthalmic solution 0.4% (Ripasudil Hydrochloride Hydrate) for glaucoma and ocular hypertension